We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.

list of NY corporations

Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug


Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many cases were asymptomatic.
read more

Source: NY Times


17:00, November 22, 2021 Pam Belluck

You may also like

News